Prevalence and correlates of hepatitis c virus infection among inmates entering the California correctional system

Western Journal of Medicine

Volumn 170, Issue 3, 1999, Pages 156-160

  Ruiz, Juan D ^a,b   Molitor, Fred ^c   Sun, Richard K ^a,b   Mikanda, John ^a,b   Facer, Matthew ^a,b   Colford Jr , John M ^e   Rutherford, George W ^f   Ascher, Michael S ^d  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b Off AIDS HIV/AIDS Epidemiol Br   (United States)

^c Maternal and Child Health Branch   (United States)

^d VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; ETHNIC GROUP; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; OFFENDER; PRISON; SEROPREVALENCE; VIRUS HEPATITIS; VIRUS TRANSMISSION;

ADULT; CALIFORNIA; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HUMANS; MALE; PREVALENCE; PRISONERS; RETROSPECTIVE STUDIES;

EID: 0032930435     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:349-362
2. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264:2231-2235
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327:1899-1905
4. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-675
5. Bradley DW. Virology, molecular biology, and serology of hepatitis C virus. Transfusion Med Rev 1992; VI:93-102
6. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26:62S-65S
7. Centers for Disease Control and Prevention. Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. Morb Mortal Wkly Rep 1991; 40(RR-4):1-13
8. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin N Am 1994; 23:437-455
9. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Inf Dis 1993; 12:673-676
10. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264:2231-2235
11. Stevens CE, Taylor PE, Pindyck J, et al. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 1990; 263:49-53
12. Nowicki MJ, Ahmad N, Heubi JE, Kuramoto JK, Baroudy BM, Balistrevi WF. The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation. Dig Dis Sci 1994; 39:2250-2254
13. Corny-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691-1696
14. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb Mortal Wkly Rep 1998; 47(RR-19):1-39
15. Crofts N, Stewart T, Hearne P, Ping XY, Breshkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995; 310:285-288
16. Prefontaine RG, Chaudhary RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia. Can Dis Wkly Rep 1990; 16-25:265-268
17. Ford PM, White C, Kaufmann H, et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995; 153:1605-1609
18. Anand CM, Fonseca K, Walle RP, Powell S, Williams M. Antibody to hepatitis C virus in selected groups of a Canadian urban population. Int J Epidemiol 1992; 21:142-145
19. Anon C, DelOlmo JA, Llovet F, et al. The hepatitis C virus among the prison population of Valencia. Rev Esp Enferm Dig 1995; 87:505-508
20. Katayama Y, Barzaga NG, Alipio A, et al. Genotype analysis of hepatitis C virus among blood donors and inmates in Metro Manila, The Philippines. Microbiol Immunol 1996; 40:525-529
21. Utsumi T, Hashimoto E, Okumura Y, et al. Heterosexual activity as a risk factor for the transmission of hepatitis C virus. J Med Virol 1995; 46:122-125
22. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9:566-569
23. Singleton JA, Perkins CI, Trachtenberg AI, Hughes MJ, Kizer KW, Ascher M. HIV antibody seroprevalence among prisoners entering the California correctional system. West J Med 1990; 153:394-399
24. Dean AG, Dean JA, Coulombier D, et al. Epi Info Version 6.0: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, Georgia: Centers for Disease Control and Prevention; 1994
25. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989
26. Hoofnagle JH. Therapy of viral hepatitis. Digestion 1998; 59:563-578
27. Food and Drug Administration Web site. Available at: http://www.fda. gov/bbs/topics/ANSWERS/ANS00929.html.